SCHEMBL9924331

SCHEMBL9924331

CCOC(=O)NC1CCC(N/C(=N\C(=O)c2cccc(OC)c2)Nc2cc(F)cc(Cl)c2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.40
MAPT P10636 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
RAB9A P51151 2/20 0.40
CCR3 P51677 1/20 0.40
CXCR6 O00574 1/20 0.39
GRM5 P41594 1/20 0.39
CHRM1 P11229 1/20 0.38
MGLL Q99685 2/20 0.38
MTNR1B P49286 2/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
MCL1 Q07820 1/20 0.37
POLB P06746 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9924257 0.92 GRM5 (0.42) NPC1MAPTMEN1KMT2ARAB9A
SCHEMBL9924256 0.91 NPC1 (0.36) NPC1MEN1KMT2ARAB9AHSD17B10
SCHEMBL9924329 0.91 SLC6A9 (0.40) MAPTKMT2ACCR3CXCR6GRM5
SCHEMBL9924077 0.90 GRM4 (0.38) MAPTKMT2AMAPK1HTTALDH1A1
SCHEMBL9924258 0.87 GRM5 (0.47) NPC1MAPTMEN1KMT2ARAB9A
SCHEMBL9924259 0.87 CHRM1 (0.38) MAPTMEN1KMT2ACHRM1POLB
SCHEMBL17206702 0.87 CHRM1 (0.38) MAPTMEN1KMT2ACHRM1POLB
SCHEMBL9924228 0.87 CHRM1 (0.38) MAPTMEN1KMT2ACHRM1POLB
SCHEMBL9924087 0.87 HSD11B1 (0.39) MAPTMEN1KMT2AHTTKDM4E
SCHEMBL9924084 0.86 GRM4 (0.35) MAPTMEN1KMT2AMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169199-B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2015-10-27 US disclosed
WO-2012078867-A2 CYCLOALKYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF LYCERA CORPORATION (US) 2012-06-14 WO disclosed